Absence of MyD88 signaling induces donor-specific kidney allograft tolerance

Journal of the American Society of Nephrology

Volumn 23, Issue 10, 2012, Pages 1701-1716

  Wu, Huiling ^a,b   Noordmans, Gerda A ^a,b   O'Brien, Maya R ^a,b   Ma, Jin ^a,b   Zhao, Cathy Y ^a,b   Zhang, Geoff Y ^c   Kwan, Tony K T ^a,b   Alexander, Stephen I ^a,c   Chadban, Steven J ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AMPICILLIN; ANTIGEN; BASILIXIMAB; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DRUG EFFICACY; EFFECTOR CELL; FLOW CYTOMETRY; HLA MATCHING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INFECTION; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SURVIVAL RATE; T LYMPHOCYTE; TH17 CELL; WILD TYPE;

EID: 84867162434     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012010052     Document Type: Article

References (58)

1. McDonald S, Russ G, Campbell S, Chadban S: Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome. Am J Transplant 7: 1201-1208, 2007 (Pubitemid 46646787)
2. Meier-Kriesche HU, Steffen BJ, Chu AH, Loveland JJ, Gordon RD, Morris JA, Kaplan B: Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival. Am J Transplant 4: 2058- 2066, 2004
3. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003 (Pubitemid 37509740)
4. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE: Cancer incidence before and after kidney transplantation. JAMA 296: 2823-2831, 2006 (Pubitemid 44969182)
5. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347: 103-109, 2002 (Pubitemid 34753480)
6. Chalasani G, Li Q, Konieczny BT, Smith-Diggs L, Wrobel B, Dai Z, Perkins DL, Baddoura FK, Lakkis FG: The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J Immunol 172: 7813-7820, 2004 (Pubitemid 38747649)
7. Obhrai J, Goldstein DR: The role of toll-like receptors in solid organ transplantation. Transplantation 81: 497-502, 2006
8. Nankivell BJ, Alexander SI: Rejection of the kidney allograft. N Engl J Med 363: 1451-1462, 2010
9. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859, 2007 (Pubitemid 47529615)
10. Anders HJ, Banas B, Schlöndorff D: Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15: 854-867, 2004 (Pubitemid 38375304)
11. Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, Wang Y, Wu QQ, Hartono JR, Winterberg PD, Lu CY: Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 79: 288-299, 2011
12. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2: 947-950, 2001 (Pubitemid 32976167)
13. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S: Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903, 2005 (Pubitemid 41434417)
14. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB: TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 178: 6252-6258, 2007 (Pubitemid 46717408)
15. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, Chadban SJ: HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 21: 1878-1890, 2010
16. Krüger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Krämer BK, Colvin RB, Heeger PS, Murphy BT, Schröppel B: Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 106: 3390-3395, 2009
17. Palmer SM, Burch LH, Davis RD, Herczyk WF, Howell DN, Reinsmoen NL, Schwartz DA: The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 168: 628-632, 2003 (Pubitemid 37175964)
18. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA: Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 20: 30-36, 2006 (Pubitemid 43349021)
19. Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P, Kazory A, Chalopin JM, Tiberghien P: Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 67: 2454-2461, 2005 (Pubitemid 41623410)
20. Goldstein DR, Tesar BM, Akira S, Lakkis FG: Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 111: 1571-1578, 2003 (Pubitemid 38063290)
21. Tesar BM, Zhang J, Li Q, Goldstein DR: TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein. Am J Transplant 4: 1429-1439, 2004 (Pubitemid 39159057)
22. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, Gretz N, Schaefer L, Kirschning CJ, Popovic ZV, Gröne HJ: Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech 3: 92-103, 2010
23. Chu CQ, Wittmer S, Dalton DK: Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 192: 123-128, 2000 (Pubitemid 30470813)
24. Kishimoto K, Sandner S, Imitola J, Sho M, Li Y, Langmuir PB, Rothstein DM, Strom TB, Turka LA, Sayegh MH: Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest 109: 1471-1479, 2002 (Pubitemid 34596173)
25. Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, Larsen CP, Pearson TC, Lakkis FG: IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 160: 2059-2064, 1998 (Pubitemid 28119882)
26. Hassan AT, Dai Z, Konieczny BT, Ring GH, Baddoura FK, Abou-Dahab LH, El-Sayed AA, Lakkis FG: Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-gamma: Implications for long-term allograft acceptance. Transplantation 68: 124-129, 1999 (Pubitemid 29352842)
27. Markees TG, Phillips NE, Gordon EJ, Noelle RJ, Shultz LD, Mordes JP, Greiner DL, Rossini AA: Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest 101: 2446-2455, 1998 (Pubitemid 28270439)
28. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ: IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 201: 1925-1935, 2005 (Pubitemid 41002929)
29. Feng G, Wood KJ, Bushell A: Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: Potential avenues for cellular therapy. Transplantation 86: 578-589, 2008
30. Feng G, Gao W, Strom TB, Oukka M, Francis RS, Wood KJ, Bushell A: Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur J Immunol 38: 2512-2527, 2008
31. Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-6177, 2003 (Pubitemid 37467240)
32. Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, Wang YH, Schluns KS, Broaddus RR, Zhu Z, Dong C: Regulation of inflammatory responses by IL-17F. J Exp Med 205: 1063-1075, 2008 (Pubitemid 351679682)
33. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L: Interleukin-17 production in central nervous system infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172: 146-155, 2008 (Pubitemid 351186376)
34. Gan PY, Steinmetz OM, Tan DS, O'Sullivan KM, Ooi JD, Iwakura Y, Kitching AR, Holdsworth SR: Th17 cells promote autoimmune antimyeloperoxidase glomerulonephritis. J Am Soc Nephrol 21: 925-931, 2010
35. Summers SA, Steinmetz OM, LiM, Kausman JY, Semple T, Edgtton KL, Borza DB, Braley H, Holdsworth SR, Kitching AR: Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol 20: 2518-2524, 2009
36. Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD: IL-17 produced by neutrophils regulates IFN-gamma mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120: 331-342, 2010
37. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY: Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 197: 322-332, 2002 (Pubitemid 34778302)
38. Hsieh HG, Loong CC, Lui WY, Chen A, Lin CY: IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int 14: 287-298, 2001 (Pubitemid 33021058)
39. Steinmetz OM, Summers SA, Gan PY, Semple T, Holdsworth SR, Kitching AR: The Th17-defining transcription factor RORγt promotes glomerulonephritis. J Am Soc Nephrol 22: 472-483, 2011
40. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, Donnarumma M, Habicht A, Clarkson MR, Iacomini J, Glimcher LH, Sayegh MH, Ansari MJ: A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 205: 3133-3144, 2008
41. Yuan X, Ansari MJ, D'Addio F, Paez-Cortez J, Schmitt I, Donnarumma M, Boenisch O, Zhao X, Popoola J, Clarkson MR, Yagita H, Akiba H, Freeman GJ, Iacomini J, Turka LA, Glimcher LH, Sayegh MH: Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc Natl Acad Sci U S A 106: 10734-10739, 2009
42. Burrell BE, Csencsits K, Lu G, Grabauskiene S, Bishop DK: CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 181: 3906-3914, 2008
43. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006
44. Afzali B, Lombardi G, Lechler RI, Lord GM: The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148: 32-46, 2007 (Pubitemid 46365005)
45. Heidt S, Segundo DS, Chadha R, Wood KJ: The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 15: 456-461, 2010
46. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036, 2003 (Pubitemid 36222922)
47. Xu L, Kitani A, Fuss I, Strober W: Cutting edge: Regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 178: 6725-6729, 2007 (Pubitemid 46847395)
48. Chen L, Ahmed E, Wang T, Wang Y, Ochando J, Chong AS, Alegre ML: TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol 182: 6217-6225, 2009
49. Torchinsky MB, Garaude J, Martin AP, Blander JM: Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458: 78-82, 2009
50. Chen L, Wang T, Zhou P, Ma L, Yin D, Shen J, Molinero L, Nozaki T, Phillips T, Uematsu S, Akira S, Wang CR, Fairchild RL, Alegre ML, Chong A: TLR engagement prevents transplantation tolerance. Am J Transplant 6: 2282-2291, 2006 (Pubitemid 44359413)
51. Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, Welsh RM, Rossini AA, Greiner DL: TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol 176: 1561-1570, 2006 (Pubitemid 43134300)
52. Porrett PM, Yuan X, LaRosa DF, Walsh PT, Yang J, GaoW, Li P, Zhang J, Ansari JM, Hancock WW, Sayegh MH, Koulmanda M, Strom TB, Turka LA: Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 181: 1692-1699, 2008
53. Walker WE, Nasr IW, Camirand G, Tesar BM, Booth CJ, Goldstein DR: Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 177: 5307-5316, 2006 (Pubitemid 44527603)
54. Wyburn K, Wu H, Chen G, Yin J, Eris J, Chadban S: Interleukin-18 affects local cytokine expression but does not impact on the development of kidney allograft rejection. Am J Transplant 6: 2612-2621, 2006 (Pubitemid 44571681)
55. Martins PN: Technique of kidney transplantation in mice with anti-reflux urinary reconstruction. Int Braz J Urol 32: 713-718, 2006
56. Wu H, Wang YM, Wang Y, Hu M, Zhang GY, Knight JF, Harris DC, Alexander SI: Depletion of gammadelta T cells exacerbates murine adriamycin nephropathy. J Am Soc Nephrol 18: 1180-1189, 2007 (Pubitemid 46536904)
57. McWhinnie DL, Thompson JF, Taylor HM, Chapman JR, Bolton EM, Carter NP, Wood RF, Morris PJ: Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 42: 352-358, 1986 (Pubitemid 16005759)
58. Wu H, Craft ML, Wang P, Wyburn KR, Chen G, Ma J, Hambly B, Chadban SJ: IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol 19: 2331-2341, 2008